दवाओं की अंतःक्रिया
Dalfampridine + Linagliptin-metformin
गंभीरता: मध्यम
Dalfampridine and Linagliptin-metformin: moderate interaction.
अंतिम अपडेट
केवल स्वास्थ्य पेशेवरों के लिए — मात्र संदर्भ हेतु। यह पृष्ठ संक्षिप्त सारांश है, चिकित्सकीय सलाह नहीं है और आधिकारिक लेबल या नैदानिक निर्णय का विकल्प नहीं है। दवा लिखने या देने से पहले हमेशा जाँच करें।
इस पृष्ठ की नैदानिक सामग्री केवल अंग्रेज़ी में उपलब्ध है।
सारांश
Both metformin and dalfampridine are eliminated partly by renal OCT2-mediated secretion, so they could compete and raise each other's concentrations. Higher dalfampridine exposure raises seizure risk, particularly in patients with reduced renal function.
इस इंटरैक्शन का सरल भाषा में अर्थ
Dalfampridine and Linagliptin-metformin can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.
Dalfampridine belongs to Central Nervous System; Linagliptin-metformin belongs to Endocrine.
ऐसा क्यों होता है
Competition at renal organic cation transporter 2 may reduce tubular secretion of both drugs.
क्या करें
Check renal function before and during co-therapy and monitor for dalfampridine toxicity such as seizures or metformin adverse effects. Avoid in patients with moderate or severe renal impairment.
फार्मासिस्ट से क्या पूछें
- Should I take them at different times of day?
- Does the dose of either medicine need to change?
- Is there anything I should avoid, such as alcohol or certain foods, while on both?
Pro+ सदस्यों के लिए
पूरा पेज खोलें
Dalfampridine और Linagliptin-metformin की पूरी प्रबंधन सलाह, अतिरिक्त नोट्स, साक्ष्य का विवरण और पूरे पर्चे का इंटरैक्शन चेकर खोलने के लिए खाता बनाएँ और Pro+ ट्रायल शुरू करें।
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
वेब पर Pro+ को 14 दिन मुफ़्त आज़माएँ। कार्ड की ज़रूरत नहीं।
Linagliptin-metformin के अन्य इंटरैक्शन
Dalfampridine के अन्य इंटरैक्शन
अक्सर पूछे जाने वाले प्रश्न
Can I take Dalfampridine with Linagliptin-metformin?
MediHelp rates the interaction as moderate. Dalfampridine and Linagliptin-metformin can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Both metformin and dalfampridine are eliminated partly by renal OCT2-mediated secretion, so they could compete and raise each other's concentrations. Higher dalfampridine exposure raises seizure risk, particularly in patients with reduced renal function.
How serious is the interaction between Dalfampridine and Linagliptin-metformin?
MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Check renal function before and during co-therapy and monitor for dalfampridine toxicity such as seizures or metformin adverse effects. Avoid in patients with moderate or severe renal impairment.
What other medicines interact with Linagliptin-metformin?
MediHelp also lists interactions of Linagliptin-metformin with, for example, Apalutamide, Carbamazepine, Contrast media. The full list is on the Linagliptin-metformin page.
MediHelp ऐप में पूर्ण मोनोग्राफ़, खुराक और इंटरैक्शन चेकर
MediHelp ऐप में पूरा संदर्भ खोलें, कई दवाओं की अंतःक्रियाएँ जाँचें और खुराक टूल इस्तेमाल करें।
